Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Adalimumab

3

IV.a Bronchospasm - Wheezing - Asthma

1
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
TNF-alpha antagonists / inhibitors
5

Publications

Chronic cough and an atypical pattern of peripheral pulmonary opacities: A case report secondary to suspected drug onset.
The Journal of asthma : official journal of the Association for the Care of Asthma 2018 Jan;55;106-110 2018 Jan
Asthma-like symptoms in a patient with rheumatoid arthritis and Adalimumab treatment.
Pneumologia (Bucharest, Romania) 2015;64;28-30 2015
Asthma unmasked with tumor necrosis factor-α-blocking drugs.
Chest 2011 Oct;140;1068-1071 2011 Oct
Bronchospasm associated with anti-TNF treatment.
Clinical rheumatology 2009 Aug;28;989-92 2009 Aug
Adalimumab-induced bronchospasm: not a class effect.
Thorax 2008 May;63;472-3 2008 May

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies